1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsClinical Trials Grants Program is sponsored by U.S. Food and Drug Administration (FDA) Office of Orphan Products Development (OOPD). This program funds clinical trials evaluating the efficacy and/or safety of products for rare diseases or conditions, including urea cycle disorders, to address unmet needs. It encourages innovative trial methods.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →According to the current listing, eligibility includes: Any foreign or domestic, public or private, for-profit or nonprofit entity (including state and local units of government) can apply. Confirm the full requirements in the official notice before applying.
Applications for Clinical Trials Grants Program are due October 20, 2026. Build your timeline backwards from this date to cover registrations, approvals, and final submission checks.
Clinical Trials Grants Program is funded by U.S. Food and Drug Administration (FDA) Office of Orphan Products Development (OOPD). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program
Efficient and Innovative Natural History Studies Addressing Unmet Needs in Rare Diseases is sponsored by U.S. Food and Drug Administration (FDA) Office of Orphan Products Development (OOPD). This program supports efficient and innovative natural history studies that advance medical product development in rare diseases/conditions with unmet needs. It aims to address critical knowledge gaps and facilitate rare disease product development.
Rare Neurodegenerative Disease Grants Program (FDA) is sponsored by U.S. Food and Drug Administration (FDA) Office of Orphan Products Development (OOPD). Awards grants and contracts to cover costs of research and development of interventions intended to prevent, diagnose, mitigate, treat or cure ALS and other rare neurodegenerative diseases in adults and children.
The AFID Infrastructure Grant program closes October 30, 2026. Awards top out at $50,000, they are reimbursable, and only a political subdivision can apply. The August round put $507,000 into 14 projects at an average of about $36,000.
Read articleThe Cold Chain Grants for Emergency Food Assistance Program closes October 1, 2026, funding cold storage equipment at up to $200,000 per project with a 10% cash match. But USDA is not awarding to food banks — it is awarding to nonprofit intermediaries who will run competitive subaward programs. Two audiences, two entirely different jobs, and one of them has 43 days.
Read articleMissouri's Department of Agriculture has reopened its Urban Agriculture Cost-Share Grant — reimbursing 75% of project costs up to $10,000, with applications due September 15, 2026. A companion Food Insecure Cost-Share Grant closes August 26. Here is how these small, fast state grants work, who qualifies under the Census 'urban area' definition, and how to layer them with the federal USDA Urban Agriculture and Innovative Production program for a durable urban-farming funding strategy.
Read article